Nebulized salbutamol diminish the blood glucose fluctuation in the treatment of non-oliguric hyperkalemia of premature infants

Journal of the Chinese Medical Association : JCMA
Hean-Pat SawJia-Yuh Chen

Abstract

Hyperkalemia is a risky and potentially life-threatening condition in pre-term infants. Glucose-insulin infusion has been considered a major therapeutic way for non-oligouric hyperkalemia but affects the stability of blood sugar level. We aimed to evaluate the effectiveness of salbutamol nebulization compared to glucose-insulin infusion for the treatment of non-oliguric hyperkalemia in premature infants. Forty premature infants (gestation age ≤36 weeks) with non-oliguric hyperkalemia (central serum potassium level greater than 6.0 mmol/L) within 72 h of birth were enrolled in this study. These infants were randomly assigned into two groups. One group received a regular insulin bolus with glucose infusion (Group A; n = 20), and the other received salbutamol (Ventolin®) by nebulization (Group B; n = 20). Potassium level, blood sugar, heart rate, and blood pressure were recorded for each group before treatment and at 3, 12, 24, 48, and 72 h post-treatment. The serum potassium levels were reduced after treatment in both groups. No significant changes in heart rate or blood pressure were observed in either group. The fluctuation in glucose levels was gentler in the salbutamol-treated group than in the glucose-insulin infusion group....Continue Reading

References

Jan 1, 1992·Journal of Perinatal Medicine·A GreenoughH R Gamsu
Jan 1, 1992·Biology of the Neonate·U DilmenI S Kaya
Mar 15, 1989·Annals of Internal Medicine·M AllonC Copkney
Aug 1, 1988·The Journal of Pediatrics·J GruskayS Baumgart
Apr 1, 1987·Archives of Internal Medicine·J MontoliuL Revert
Oct 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M Allon, N Shanklin
Feb 1, 1994·Archives of Disease in Childhood·R J McClureJ T Brocklebank
Feb 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H H LiouW C Yang
Jul 1, 1997·The Journal of Pediatrics·J M LorenzK Markarian
Mar 26, 2003·Acta Paediatrica·T GrammatikopoulosM Davenport
Feb 8, 2005·Biology of the Neonate·Sze May NgAnthony J B Emmerson
Jan 3, 2006·The Journal of Allergy and Clinical Immunology·Malcolm Johnson
Mar 15, 2006·Biology of the Neonate·Paul J Rozance, William W Hay
Aug 25, 2006·Journal of Perinatology : Official Journal of the California Perinatal Association·L S KaoK A Kennedy
Sep 16, 2006·Journal of Cutaneous Pathology·Jeremy MossRossitza Lazova
Mar 23, 2007·Journal of Perinatology : Official Journal of the California Perinatal Association·S RugolottoS Pecori
Dec 25, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Anja Lehnhardt, Markus J Kemper
Nov 20, 2012·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Milan R RadovanovićMirjana S Radovanović
Apr 4, 2013·Yonsei Medical Journal·Jae Ryoung KwakSung Hwan Kim
Apr 23, 2013·Pediatric Cardiology·Gaurav JawaKambiz Norozi
Jun 7, 2014·Archives of Medical Science : AMS·Jagadish KhanagaviStephen Peterson
Aug 5, 2014·Current Pediatric Reviews·Marta Suarez-Rivera, Melvin Bonilla-Felix
May 20, 2015·Journal of Pediatric Gastroenterology and Nutrition·Thibault SenterreJacques Rigo
May 25, 2016·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ji Lee, Brady S Moffett
Apr 6, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Melvin Bonilla-Félix

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.